Halper Sadeh LLC Investigates Masimo and Kennedy-Wilson for Shareholder Rights Violations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy MASI?
Source: Globenewswire
- Legal Investigation Launched: Halper Sadeh LLC is investigating Masimo Corporation and Kennedy-Wilson Holdings, Inc. for potential violations of federal securities laws and breaches of fiduciary duties, which may impact shareholder rights and investment returns.
- Masimo Transaction Details: Masimo is being sold to Danaher Corporation for $180.00 per share in cash, a deal that may limit the emergence of superior competing offers, thereby affecting shareholder choices and potential gains.
- Kennedy-Wilson Background: Kennedy-Wilson's sale price is set at $10.90 per share, with the buyer being a consortium led by CEO William McMorrow, and the terms of this deal may adversely affect shareholder interests, prompting Halper Sadeh LLC to seek increased consideration.
- Shareholder Rights Protection: Halper Sadeh LLC encourages shareholders to contact them to discuss their rights and options, promising to provide legal services without upfront costs, aiming to secure additional rights and compensation for affected investors.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MASI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MASI
Wall Street analysts forecast MASI stock price to rise
6 Analyst Rating
4 Buy
2 Hold
0 Sell
Moderate Buy
Current: 175.350
Low
162.00
Averages
188.40
High
210.00
Current: 175.350
Low
162.00
Averages
188.40
High
210.00
About MASI
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Announcement: Masimo (MASI) is set to announce its Q4 earnings on February 26 after market close, with consensus EPS estimate at $1.47, reflecting an 18.3% year-over-year decline, and revenue estimate at $408.33 million, down 32.0% year-over-year, indicating significant performance challenges for the company.
- Performance Expectations: Over the past two years, Masimo has beaten both EPS and revenue estimates 100% of the time, showcasing the company's reliability in financial forecasting and maintaining market confidence despite current pressures.
- Revision Trends: In the last three months, EPS estimates have seen one upward revision with no downward adjustments, while revenue estimates have experienced two upward revisions, reflecting analysts' optimistic outlook for Masimo's future performance despite the overall weak expectations.
- Acquisition Impact: Masimo's stock surged to $180 per share following the acquisition deal with Danaher, which is viewed as a strategic rescue amid lackluster performance, potentially providing new growth momentum for the company moving forward.
See More

- Legal Investigation Launched: Halper Sadeh LLC is investigating Masimo Corporation and Kennedy-Wilson Holdings, Inc. for potential violations of federal securities laws and breaches of fiduciary duties, which may impact shareholder rights and investment returns.
- Masimo Transaction Details: Masimo is being sold to Danaher Corporation for $180.00 per share in cash, a deal that may limit the emergence of superior competing offers, thereby affecting shareholder choices and potential gains.
- Kennedy-Wilson Background: Kennedy-Wilson's sale price is set at $10.90 per share, with the buyer being a consortium led by CEO William McMorrow, and the terms of this deal may adversely affect shareholder interests, prompting Halper Sadeh LLC to seek increased consideration.
- Shareholder Rights Protection: Halper Sadeh LLC encourages shareholders to contact them to discuss their rights and options, promising to provide legal services without upfront costs, aiming to secure additional rights and compensation for affected investors.
See More
- Transaction Investigation: Halper Sadeh LLC is investigating the sale of Masimo Corporation to Danaher Corporation for $180.00 per share in cash, which may affect shareholder rights and options.
- Shareholder Rights Protection: The firm encourages shareholders of Masimo and Thermon Group Holdings to reach out to discuss their rights, offering no-cost legal consultations to ensure their interests are protected in the transactions.
- Complexity of Transaction Terms: Thermon shareholders can choose between cash, CECO stock, or a combination, specifically $10.00 in cash plus 0.6840 shares of CECO stock, or $63.89 per share, or 0.8110 shares of CECO stock per share, highlighting the diversity of transaction terms.
- Post-Merger Shareholder Structure: The merger between CECO Environmental Corp. and Thermon is expected to result in CECO shareholders owning approximately 62.5% of the combined company, which may influence future corporate governance and decision-making.
See More
- Shareholder Compensation Investigation: Monteverde Law Firm is investigating the acquisition of Kennedy-Wilson Holdings, Inc. (NYSE:KW) by a consortium led by William McMorrow, with shareholders expected to receive $10.90 per share in cash, highlighting the firm's commitment to shareholder rights.
- Masimo Corporation Transaction: Masimo Corporation (NASDAQ:MASI) has reached an acquisition agreement with Danaher Corporation, with shareholders set to receive $180.00 per share in cash, indicating strong market confidence in the company's valuation.
- Arcellx Acquisition: Arcellx, Inc. (NASDAQ:ACLX) is being acquired by Gilead Sciences, Inc., with shareholders expected to receive $115.00 per share in cash plus a contingent value right of $5.00 per share, which incentivizes shareholders to focus on the company's future milestones.
- Veris Residential Deal: Veris Residential, Inc. (NYSE:VRE) is set to be acquired by an investor consortium led by Affinius Capital, with shareholders expected to receive $19.00 per share in cash, enhancing the company's competitive position in the real estate market.
See More
- Masimo Acquisition Agreement: Masimo Corporation's shares surged over 34% on Tuesday following Danaher Corporation's agreement to acquire the company for $180 per share in cash, representing a total enterprise value of approximately $9.9 billion, indicating strong market confidence in Masimo's future growth prospects.
- RingCentral Strong Earnings: RingCentral's stock jumped over 32% after its latest earnings release, reporting Q4 EPS of $1.18, exceeding the analyst estimate of $1.14, with revenue of $644 million meeting expectations, showcasing the company's ongoing efforts in innovation and product launches.
- Global Payments Earnings Growth: Global Payments' stock rallied over 16% on Wednesday and climbed an additional 2% on Friday, currently trading around $81.83, with Q4 EPS of $3.18 surpassing estimates, and the company expects adjusted EPS growth of 13% to 15% in 2026, reflecting strong future growth potential.
- Klarna Stock Plunge: Klarna's shares plummeted over 26% following its latest earnings report, despite quarterly revenue of $1.08 billion slightly exceeding expectations, as analysts expressed caution regarding its future outlook, anticipating underwhelming performance in 2026, which reflects market concerns about its profitability.
See More
- Legal Investigation Initiated: Halper Sadeh LLC is investigating VerifyMe, Inc.'s merger with Open World Ltd. for potential breaches of fiduciary duties to shareholders, aiming to protect investor rights and ensure transparency.
- Acquisition Deal Scrutiny: Masimo Corporation's sale to Danaher Corporation for $180.00 per share raises concerns about shareholder rights, with Halper Sadeh LLC potentially seeking increased consideration or other remedies.
- Shareholder Rights Protection: Valaris Limited's sale to Transocean Ltd. for 15.235 shares of Transocean stock per common share prompts Halper Sadeh LLC to encourage Valaris shareholders to understand their legal rights to ensure fair treatment in the transaction.
- Investor Advocacy Actions: Halper Sadeh LLC represents investors globally, focusing on combating securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors, showcasing its expertise in safeguarding investor rights.
See More






